Abstract
TOR (target of rapamycin) is a phosphatidylinositol kinase-related protein kinase that controls cell growth in response to nutrients. Rapamycin is an immunosuppressive and anticancer drug that acts by inhibiting TOR. The modes of action of TOR and rapamycin are remarkably conserved from S. cerevisiae to humans. The current understanding of TOR and rapamycin is derived largely from studies with S. cerevisiae. In this review, we discuss the contributions made by S. cerevisiae to understanding rapamycin action and TOR function.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Antifungal Agents / metabolism
-
Antifungal Agents / pharmacology*
-
Cell Cycle Proteins
-
Fungal Proteins / metabolism
-
Fungal Proteins / physiology*
-
Humans
-
Immunosuppressive Agents / metabolism
-
Immunosuppressive Agents / pharmacology*
-
Phosphatidylinositol 3-Kinases*
-
Phosphotransferases (Alcohol Group Acceptor) / metabolism
-
Phosphotransferases (Alcohol Group Acceptor) / physiology*
-
Ribosomes / metabolism
-
Saccharomyces cerevisiae / drug effects
-
Saccharomyces cerevisiae / metabolism*
-
Saccharomyces cerevisiae / physiology
-
Saccharomyces cerevisiae Proteins*
-
Signal Transduction / physiology
-
Sirolimus / metabolism
-
Sirolimus / pharmacology*
-
Tacrolimus Binding Protein 1A / metabolism
Substances
-
Antifungal Agents
-
Cell Cycle Proteins
-
Fungal Proteins
-
Immunosuppressive Agents
-
Saccharomyces cerevisiae Proteins
-
Phosphotransferases (Alcohol Group Acceptor)
-
TOR1 protein, S cerevisiae
-
TOR2 protein, S cerevisiae
-
Tacrolimus Binding Protein 1A
-
Sirolimus